CTL Amedica

Executive Summary

CTL Amedica is a privately held medical device company headquartered in Salt Lake City, Utah, specializing in spinal implants and regenerative medicine solutions. Founded in 2008, the company develops innovative spinal systems designed to improve surgical outcomes and patient recovery. Its product portfolio includes a range of interbody fusion devices and biologics, marketed under artist-inspired names to emphasize precision and craftsmanship. Despite limited public information, CTL Amedica aims to differentiate itself through advanced technology and clinical evidence. The company operates in the competitive spinal market, where differentiation through innovation and proven results is critical. As a private entity, it may be seeking strategic partnerships or additional funding to scale commercialization. Given the lack of recent FDA approvals or disclosed clinical milestones, the company's near-term trajectory is uncertain, but its focus on regenerative medicine could offer long-term growth potential if it achieves regulatory breakthroughs or secures distribution agreements.

Upcoming Catalysts (preview)

• Q2 2026FDA 510(k) clearance for a new spinal implant system60% success
• Q3 2026Announcement of a strategic distribution partnership50% success
• Q4 2026Publication of positive clinical outcomes for regenerative spine product40% success